Espoo, Finland, March 2023. Research points out that microorganisms play a role in many aspects of human health. Consequently, more and more people
Espoo, Finland, February 2023. Euformatics, a global leader in NGS data quality control and variant interpretation, together with ViennaLab
Espoo, Finland, January 2023. Folkhälsan Research Center, has chosen Euformatics as the provider of NGS secondary analysis and variant
Espoo, Finland, December 2022. Euformatics, a global leader in NGS data quality control and variant interpretation, together with Finland’s BC
HELSINKI, Finland, September 2022. Euformatics, a Finnish company providing services for NGS variant interpretation and quality control, had
ESPOO, Finland, July 1st 2022. Finnish IT company Euformatics has been awarded a grant from the European Commission’s Recovery and Resilience
HELSINKI, Finland May 2022. Euformatics, BC Platforms and Oncompass Medicine formed a partnership to bid for the development of standardized
